Asset Details
Do you wish to reserve the book?
The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy
Do you wish to request the book?
The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy
2020
Overview
Following its discovery more than 30 years ago, the enhanced permeability and retention (EPR) effect has become the guiding principle for cancer nanomedicine development. Over the years, the tumor-targeted drug delivery field has made significant progress, as evidenced by the approval of several nanomedicinal anticancer drugs. Recently, however, the existence and the extent of the EPR effect - particularly in patients - have become the focus of intense debate. This is partially due to the disbalance between the huge number of preclinical cancer nanomedicine papers and relatively small number of cancer nanomedicine drug products reaching the market. To move the field forward, we have to improve our understanding of the EPR effect, of its cancer type-specific pathophysiology, of nanomedicine interactions with the heterogeneous tumor microenvironment, of nanomedicine behavior in the body, and of translational aspects that specifically complicate nanomedicinal drug development. In this virtual special issue, 24 research articles and reviews discussing different aspects of the EPR effect and cancer nanomedicine are collected, together providing a comprehensive and complete overview of the current state-of-the-art and future directions in tumor-targeted drug delivery.
Publisher
Ivyspring International Publisher Pty Ltd,Ivyspring International Publisher
Subject
/ Animals
/ Antineoplastic Agents - administration & dosage
/ Antineoplastic Agents - pharmacokinetics
/ Drug Delivery Systems - methods
/ Humans
/ Hypoxia
/ Kinases
/ Ligands
/ Nanoparticles - administration & dosage
/ Neoplasms - diagnostic imaging
/ Patients
/ Theranostic Nanomedicine - methods
/ Tumor Microenvironment - drug effects
/ Tumors
We currently cannot retrieve any items related to this title. Kindly check back at a later time.